US Bill directs VA to adopt 4D lung imaging
Open PDF
| Stock | 4DMEDICAL Ltd (4DX.ASX) |
|---|---|
| Release Time | 16 Jul 2026, 12:31 p.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
US Bill Directs VA to Adopt 4D Lung Imaging
Key Points
- A bipartisan bill introduced in the US House of Representatives directs the VA to establish a pilot program using 4D lung imaging software.
- The bill authorizes $20 million for the pilot program.
- 4DMedical's XV Technology® is positioned to benefit from this initiative.
Full Summary
4DMedical Limited, a global leader in respiratory imaging technology, announced the introduction of a bipartisan bill in the US House of Representatives (H.R.9666) directing the Department of Veterans Affairs (VA) to establish a pilot program using 4D functional lung imaging to identify respiratory disorders and lung disease in veterans. The bill, introduced by Representatives Juan Ciscomani (R, Arizona) and Chris Pappas (D, New Hampshire), authorizes $20 million for the pilot. 4DMedical's XV Technology®, an FDA-cleared product, fits the bill's definition of eligible imaging software. The company is well-positioned to support the VA's pilot program.
Guidance
None
Outlook
None
Sign in to get more information about the company, including guidance changes and other insights.
Sign In